Showing posts with label Bioventus. Show all posts
Showing posts with label Bioventus. Show all posts
Friday, July 12, 2013
Bioventus names new chief science officer
Biologics firm Bioventus has appointed Alessandra Pavesio to become the
company’s new chief science officer.
Wednesday, July 3, 2013
Durham’s Bioventus Gets Deal with Pfizer
Durham-based Bioventus has nabbed a big pharma platform for its orthopaedic healing portfolio: Pfizer’s bone morphogenetic protein.
Subscribe to:
Posts (Atom)